Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

A pill Novo acquired produced modest weight loss but raised safety questions. Elsewhere, Sanofi detailed the silver lining it found in a recent study and a heart drug developer’s shares surged.

No surprise that Apple’s annual September event included a brand new iPhone. This one, dubbed iPhone 16, was "designed around ...

A groundbreaking review how AI is revolutionizing the field of emotional recognition, promising to transform everything from ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $508.38, a high estimate of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Design My Trip’ helps travelers plan their trips to Thailand within seconds, supporting the country’s international tourism ...

Some people of West African of descent face a higher risk of renal failure. New drugs based on gene research may help right ...

As global markets rebound from recent sell-offs, technology stocks have led the charge, significantly outpacing their value counterparts. With the S&P 500 Index recovering from its steepest decline ...

Design My Trip' helps travelers plan their trips to Thailand within seconds, supporting the country's international tourism ...

Improving sickle cell care by expanding treatment options, advancing new therapies and amplifying the voices of people with ...

And both are under priority review. So one is our vanzacaftor triple ... And we intend to fully develop both of these markets at Vertex. We see them both as specialty markets. And longer-term, given ...